European experts fear that routine vCJD (variant Creuzfeldt Jacob disease) blood test could deter donors
This article was originally published in Clinica
Screening blood donations for variant Creuzfeldt Jacob disease (vCJD) when a suitable assay becomes available could lead to a significant lack of donors, the European Commission's Scientific Committee on Medicinal Products and Medical Devices (SCMPMD) has warned.
You may also be interested in...
Demand for tele-diagnostic tools has reached unprecedented levels during COVID-19, said Kees Wesdrop, Royal Philips’ chief business leader of precision diagnosis.
Transparency On COVID Vaccine Clinical Holds Needed, Sharfstein Says; US FDA Advisory Cmtes Offer Venue
Former acting Commissioner Josh Sharfstein argues that while agency officials have done a commendable job in overall communication on COVID vaccine development, more information is needed on the clinical holds.
Trump administration effort to reduce drug prices by curtailing agency program requiring new approvals for some old products undermines FDA’s role in policing the safety of prescription drugs, experts say.